With a 2-minute efficacy claim against 60 pathogens from a quat-alcohol formulation, CaviWipes 2.0 is optimized to meet your needs today and in the future by fully qualifying for the EPA's rigorous Emerging Viral Pathogen Claim, and is on EPA List Q.
efficacy-claims (1)
Enhanced Efficacy Claims - 60 Pathogens
Effective 1-step cleaning/disinfection2 against 60 pathogens including SARS-CoV-2,
Candida auris and 11 MDROs (Multidrug Resistant Organisms), for added confidence in preventing healthcare-associated infections.
2-min-contact-time (2)
2-Minute Contact Time
2-minute universal contact time for bacteria, viruses, and pathogenic fungi.
compatibility (1)
Excellent Material Compatibility
Similar to CaviWipes™ original formula, compatible with hard, non-porous surfaces commonly used in clinical settings.
pathogens (1)
Fully Qualified for the Emerging Viral Pathogen Claim
Qualifies for the EPA’s Emerging Viral Pathogens claim for all virus types (enveloped,
large and small non-enveloped viruses) to meet current and potentially future infection
prevention needs.
Ordering Information
Part #  Description
14-1100 CaviWipes 2.0 (6” x 6.75”) – 160 towelettes per canister
14-1150 CaviWipes 2.0 XL (9” x 12”) – 65 towelettes per canister

 

 
* List N: Disinfectants for Use Against SARS-CoV-2. Feb 28, 2022, www.epa.gov/pesticide-registration/list-n-disinfectants-use-against-sars-cov-2.
** Precleaning is required when visibly soiled and/or disinfecting against Candida auris, HIV, HBV and HCV
*** Data on file.